The long-running dispute over the Shiv Sena’s identity and election symbol has returned to the spotlight during a hearing in the Supreme Court. The Eknath Shinde faction has questioned the validity of a legislative party meeting held on June 21, 2022, arguing that the notice informing Shinde about the meeting was delivered after it had already begun.

Senior Advocate Dhruv Mehta, representing Shinde and other legislators, told a three-judge bench that a WhatsApp message regarding the meeting was sent to Shinde’s personal assistant at 12:31 pm, while the meeting had been scheduled to begin at 12:30 pm. He argued that the communication was merely an invitation to attend a meeting and not a formal whip.

Dispute Over Disqualification The Shinde faction maintained that a legislator’s absence from a party meeting cannot automatically be treated as voluntarily giving up membership of the political party under the Tenth Schedule of the Constitution. Mehta argued that internal disagreement or dissent should not be equated with defection.

He also questioned the reliability of the attendance register presented by the Uddhav Thackeray faction and raised allegations of irregularities in certain signatures. These claims remain submissions made before the court and have not been established through a judicial finding.

Party Symbol Case Also Under Consideration The Supreme Court is hearing the Uddhav Thackeray faction’s challenge to the Maharashtra Assembly Speaker’s decision not to disqualify Shinde-group legislators. A connected petition also challenges the Election Commission’s decision recognising the Shinde faction as the official Shiv Sena and allotting it the traditional bow-and-arrow symbol.

The matter is being heard by a bench comprising Chief Justice Surya Kant and Justices Joymalya Bagchi and V. Mohana. The arguments are continuing, and the court has not yet delivered its final decision on the dispute.


Hashtags: #MumbaiCity #Bhopal #Shinde #Faction #Questions #Shiv #Sena #Meeting #Notice #ShindeFactionQuestionsShiv